These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38860720)

  • 21. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
    Li C; Cheng G
    Front Immunol; 2020; 11():1969. PubMed ID: 32849658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
    Choudhuri AH; Duggal S; Ahuja B; Biswas PS
    Indian J Med Microbiol; 2021 Apr; 39(2):159-170. PubMed ID: 33781656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
    Voisin O; Lorc'h EL; Mahé A; Azria P; Borie MF; Hubert S; Ménage E; Guillerm JC; Mourad JJ
    Mayo Clin Proc; 2020 Aug; 95(8):1696-1700. PubMed ID: 32753141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
    García-Fernández A; Ramos-Ruiz P; Ibáñez-Criado A; Moreno-Pérez Ó; Cambra-Poveda C; Martínez-Martínez JG;
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):108-111. PubMed ID: 33077410
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
    Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
    Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
    Juurlink DN
    CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 30. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis.
    Risch HA
    Am J Epidemiol; 2020 Nov; 189(11):1218-1226. PubMed ID: 32458969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials.
    Kamel AM; Monem MSA; Sharaf NA; Magdy N; Farid SF
    Rev Med Virol; 2022 Jan; 32(1):e2258. PubMed ID: 34077600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
    Baralić K; Jorgovanović D; Živančević K; Antonijević Miljaković E; Antonijević B; Buha Djordjevic A; Ćurčić M; Đukić-Ćosić D
    Toxicol Appl Pharmacol; 2020 Nov; 406():115237. PubMed ID: 32920000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety profile of COVID-19 drugs in a real clinical setting.
    Chiu MN; Bhardwaj M; Sah SP
    Eur J Clin Pharmacol; 2022 May; 78(5):733-753. PubMed ID: 35088108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions for palliative symptom control in COVID-19 patients.
    Andreas M; Piechotta V; Skoetz N; Grummich K; Becker M; Joos L; Becker G; Meissner W; Boehlke C
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD015061. PubMed ID: 34425019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
    Pani A; Lauriola M; Romandini A; Scaglione F
    Int J Antimicrob Agents; 2020 Aug; 56(2):106053. PubMed ID: 32534189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
    Okumuş N; Demirtürk N; Çetinkaya RA; Güner R; Avcı İY; Orhan S; Konya P; Şaylan B; Karalezli A; Yamanel L; Kayaaslan B; Yılmaz G; Savaşçı Ü; Eser F; Taşkın G
    BMC Infect Dis; 2021 May; 21(1):411. PubMed ID: 33947344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.
    Damle B; Vourvahis M; Wang E; Leaney J; Corrigan B
    Clin Pharmacol Ther; 2020 Aug; 108(2):201-211. PubMed ID: 32302411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
    Goldman JD; Diaz G; Urba WJ
    Int J Antimicrob Agents; 2021 Jan; 57(1):106174. PubMed ID: 33408020
    [No Abstract]   [Full Text] [Related]  

  • 40. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
    Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN
    Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.